Skip to main content

1 Result(s)

within Esther Natalie Oliva Remove this filter Internal Medicine Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS

    Erythropoiesis-stimulating agents are first choice for treating anemia in low-risk MDS. This double-blind, placebo-controlled study assessed the efficacy and safety of epoetin-α in IPSS low- or intermediate-1 ...

    Pierre Fenaux, Valeria Santini, Maria Antonietta Aloe Spiriti… in Leukemia (2018)

    Download PDF (1133 KB) View Article